Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/23/2003CN1413197A 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413192A Substituted indole mannich bases
04/23/2003CN1413190A EP4 receptor selective agonists in treatment of osteoporosis
04/23/2003CN1413189A Benzamidine derivatives
04/23/2003CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
04/23/2003CN1413185A Substitued 1 and 2 naphthol mannich bases
04/23/2003CN1413184A Novel compounds to treat diabetes and associated conditions
04/23/2003CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
04/23/2003CN1413120A Method of inactivating pathogens
04/23/2003CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof
04/23/2003CN1413117A Drugs, drinks or foods
04/23/2003CN1413114A System for stabilizing lacrimal fluid layer
04/23/2003CN1413113A Method of treating gastrointestinal tract disease using purinergic receptor agonists
04/23/2003CN1413112A Nasal drops containing fused pyridazine derivatives
04/23/2003CN1413111A Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
04/23/2003CN1413110A Pharmaceutical composition
04/23/2003CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels
04/23/2003CN1413108A 6-methoxy-2-naphthylacetic acid prodrugs composition for curing inflammation
04/23/2003CN1413107A Use of hypoglycemic agent for treating impaired clucose metabolism
04/23/2003CN1413106A 6-methoxy-2-naphthylacetic acid prodrugs for curing inflammation
04/23/2003CN1413105A Novel method of treatment
04/23/2003CN1413104A New (aminopropyl) methylphosphinic acids
04/23/2003CN1413100A Local prevention or amelioration of pain from surgically closed wounds
04/23/2003CN1412202A Ganoderma applanatum polysaccharide, its preparation and medicine composition using said compound as active component
04/23/2003CN1412187A Nicotinamidobenzozine and its application
04/23/2003CN1412185A Production method of halogenated hexahydroxydiphenic derivative and its medicinal application
04/23/2003CN1412182A Tetrahydroisoquinoline derivative with antifungal activity and its preparation method
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411858A Medicine for curing scald and bed sore
04/23/2003CN1411849A Preparation for relieving alcoholism
04/23/2003CN1411844A Weight-reducing Chinese medicine acted on acupoint
04/23/2003CN1411825A Medicine for curing burn and scald and its production method
04/23/2003CN1411816A New anticoagulant medicine
04/23/2003CN1411815A Baicalin eye drops and its preparation method
04/23/2003CN1411814A Eye lotion
04/23/2003CN1411813A Theobromine with anticancer activity
04/23/2003CN1411812A Oral medicine preparation with high absorbency
04/23/2003CN1411811A 血液循环改善剂 Blood circulation improving agent
04/23/2003CN1411810A Fatigue-resistant drug composition
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411808A N-acetyl-5,6-dimethoxytryptamine for preparing medicine resisting oxidation free radical
04/23/2003CN1411807A Medicine for curing hoary hair and its preparation method
04/23/2003CN1411806A Bromhexine hydrochloride injection and its preparation method
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106399C Process for preparing sildenafil
04/23/2003CN1106395C Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
04/23/2003CN1106394C Dihydrobenzopyran and dihydrobenzopyran compound and their use
04/23/2003CN1106391C Magnolol series compounds and synthesizing process thereof, and medicinal composition using same as active component
04/23/2003CN1106390C Tachykinin receptor antagonist substituted methyl keto-morpholine crystal form
04/23/2003CN1106389C Efficient enantioselective addition reaction using organozinc reagent
04/23/2003CN1106387C PDEIV inhibiting 2-cyanoiminoimidazole derivatives
04/23/2003CN1106386C Parasiticidal pyrazole compound
04/23/2003CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions
04/23/2003CN1106383C Estrogenic agents
04/23/2003CN1106380C New synthetic catechol derivatives, method for production and use thereof
04/23/2003CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants
04/23/2003CN1106376C Cinnamylidene camphor derivatives and their use as UV-A optical protecting agents
04/23/2003CN1106375C Method for preparing substituted anthraquinone
04/23/2003CN1106203C Chlamydia vaccine and process
04/23/2003CN1106202C Anti-aids immunomodulator complex
04/23/2003CN1106200C Togluo Ruanjiangao plaster and its preparing method
04/23/2003CN1106197C Injection for curing optic atrophy disease
04/23/2003CN1106196C Application of Odenping medicine for treating migraine pain
04/23/2003CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
04/23/2003CN1106194C 组合物 The composition
04/23/2003CN1106193C Anticonvulsant sulfamate derivs. useful in treating obesity
04/23/2003CN1106192C Oil in water emulsions containing 2,6,-diisopropyl phenic and ehtylenedinamine-tetraacetic salt
04/23/2003CN1106191C Methyl-naphthyl-oxythiophene-propyl amine enteric pellets
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003USRE38090 Antitumor activity; useful for treatment and prevention of cancers
04/22/2003US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia
04/22/2003US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552206 Isolated n-benzyl-9-oxo-16-hydroxy-octadeca-10,12,14-triene amide; treating and preventing cancer and sexual dysfunction
04/22/2003US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
04/22/2003US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
04/22/2003US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/22/2003US6552196 Quinolone carboxylic acid derivatives
04/22/2003US6552192 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
04/22/2003US6552185 Acidifying and/or contacting with carbon dioxide followed by adsorption chromatography
04/22/2003US6552183 Moncyclic L-nucleosides analogs
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating
04/22/2003US6552089 Method of treating or preventing alopecia
04/22/2003US6552088 Biphenyl derivatives
04/22/2003US6552087 Therapeutic agent comprising (+)-sibutramine
04/22/2003US6552086 For therapy of psychiatric and neurological disorders
04/22/2003US6552085 Compositions containing hypoglycemically active stilbenoids
04/22/2003US6552083 Administering therapeutically effective amount of N-(3,4-dimethoxycinnamoyl)anthranilic acid or its salt
04/22/2003US6552082 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product
04/22/2003US6552081 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
04/22/2003US6552078 6-methoxy-2-naphthylacetic acid prodrugs
04/22/2003US6552077 Kidney disorders
04/22/2003US6552075 Therapeutic compounds and methods of use
04/22/2003US6552074 Arginine/ascorbic acid mixed powder as an oral supplement
04/22/2003US6552073 Compounds and methods of treating cell proliferative diseases
04/22/2003US6552072 Diarrhea
04/22/2003US6552071 Methods for treating cell death diseases and inflammation
1 ... 5494 5495 5496 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 5513 5514 ... 7860